VIVO Financial Facts

AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED: -84.82M
COST OF SALES: 17.28M
See Full Income Statement

Goodwill: 61.98M
Inventories: -79.06M
See Full Balance Sheet

Meridian Bioscience Inc. (VIVO) Earnings

  |   Expand Research on VIVO
Next EPS Date 12/3/26 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +39.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
9/10/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/8/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/7/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/3/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
8/31/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
6/3/26 Q226 N/AN/A N/A N/AN/A N/A N/A N/A
1/26/23 Q123 N/A$0.20 N/A N/A$72.3M N/A N/A N/A
11/14/22 Q422 N/A$0.12 N/A N/A$63M = N/A N/A